SCHEMBL7785887

SCHEMBL7785887

CNC(=O)NCc1ccccc1-c1ccc(CN2C(=O)[C@H](NC(=O)CC(C)(C)N)CCc3cc(SC)ccc32)cc1

nearest known ligand 0.69

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 4/20 0.69
AGTR1 P30556 1/20 0.55
XIAP P98170 10/20 0.44
NPY1R P25929 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7792107 0.94 GHSR (0.69) GHSRAGTR1XIAPNPY1R
SCHEMBL7792006 0.93 GHSR (0.70) GHSRAGTR1XIAPNPY1R
SCHEMBL7791967 0.93 GHSR (0.59) GHSRAGTR1XIAPNPY1R
SCHEMBL8331001 0.92 GHSR (0.81) GHSRAGTR1XIAPNPY1R
SCHEMBL7791579 0.92 GHSR (0.65) GHSRAGTR1XIAPNPY1R
SCHEMBL7791981 0.90 GHSR (0.71) GHSRAGTR1XIAPNPY1R
SCHEMBL7785968 0.90 GHSR (0.84) GHSRAGTR1XIAPNPY1R
SCHEMBL29958746 0.90 GHSR (0.84) GHSRAGTR1XIAPNPY1R
SCHEMBL7786051 0.90 GHSR (0.63) GHSRAGTR1XIAPNPY1R
SCHEMBL7796120 0.89 GHSR (0.69) GHSRAGTR1XIAPNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659179-B1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO INC (US) 2001-11-21 EP claimed
EP-0659179-B1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO INC (US) 2001-11-21 EP disclosed
US-5968924-A HAVE THE ABILITY TO STIMULATE THE RELEASE OF NATURAL OR ENDOGENOUS GROWTH HORMONE; TREATMENT OF OBESITY, OSTEOPOROSIS MERCK & CO., INC. (US) 1999-10-19 US disclosed
WO-1994005634-A1 BENZO-FUSED LACTAMS PROMOTE RELEASE OF GROWTH HORMONE MERCK & CO., INC. (US) 1994-03-17 WO disclosed